官方服务：
资源简介：
R package for multiple myeloma prognostic signatures and gene expression based signature index calculation.
应用场景：
创建时间：
2016-10-19
相关数据集
Comprehensive Homozygous Deletion Mapping of Myeloma Defines a Poor Prognosis Cell Death Gene Expression Signature
Myeloma is a clonal malignancy of plasma cells. Poor prognosis risk is currently identified by clinical and cytogenetic features. However, these indicators do not capture all prognostic information.
NIAID Data Ecosystem50
Additional file 2 of The importance of censoring in competing risks analysis of the subdistribution hazard
Multiple myeloma data. Survival data from the multiple myeloma example used in this paper, including the donor KIR haplotype, event times and types (0 = censored, 1 = relapse, 2 = transplant-related d
Figshare2017-04-05 更新20
Univariate Cox regression analysis for factors influencing time to progression in multiple myeloma.
Footnote: CI, confidence interval; ISS, international staging system; M protein, monoclonal protein; β2-M, β2 microglobulin; BMPCs, bone marrow plasma cells; N-PCs, normal plasma cells.
Figshare2015-12-02 更新10
Multivariate Analysis of Risk Factors for PFS and OS.
Abbreviations: OS, overall survival; PFS, progression-free survival; HR, hazard ratio; CI, confidence intervals; DS, Durie-Salmon; ISS, International Staging System; FISH, interphase fluorescence in s
NIAID Data Ecosystem30
TMEM97 is correlated with the clinical features and clinical prognosis, and acts as a potential marker of multiple myeloma
Abstract Background: TMEM97 has been proven to be involved in many biological processes of malignancies. This study was designed to investigate the role of TMEM97 in multiple myeloma progression and
NIAID Data Ecosystem20
